Wang, Ton https://orcid.org/0000-0003-0437-3771
Neish, Drew
Thomas, Samantha
Botty van den Bruele, Astrid
Rosenberger, Laura H.
Chiba, Akiko
Parrish, Kendra
Dossett, Lesly A.
DiLalla, Gayle
Plichta, Jennifer K.
DiNome, Maggie L.
Hwang, E. Shelley
Ayala-Peacock, Diandra
Funding for this research was provided by:
National Cancer Institute (P30CA014236)
Article History
Received: 25 August 2025
Accepted: 3 November 2025
First Online: 23 November 2025
Disclosure
: The authors report no proprietary or commercial interest in any product mentioned or concept discussed in this article. Dr. A. Botty van den Bruele is a member of the National Comprehensive Cancer Network (NCCN) Breast Cancer Diagnosis and Screening Committee. Dr. J.K. Plichta is supported in part through NIH grant K12AR084231 (PI: Amundsen). She is a member of Editorial Committee for the American Joint Committee on Cancer (AJCC), the Breast Panel for the AJCC, and the NCCN Genetic/Familial High-Risk Assessment: Breast, Ovarian, Pancreatic, and Prostate Committee. S.M. Thomas is a member of the Evidence-Based Medicine Committee for the AJCC, the Breast Panel for the AJCC, and the Neuroendocrine Tumor Panel for the AJCC. This work was supported in part by the Duke Cancer Institute through NIH grant P30CA014236 (PI: Kastan) for the Biostatistics Core. Dr. E.S. Hwang serves on the National Cancer Institute (NCI) Breast Cancer Steering Committee and the NCCN Breast Cancer Prevention Committee. Dr L.H. Rosenberger serves on the NCCN Breast Cancer Committee.